ADMA
ADMA BIOLOGICS, INC.
+0.04 (+0.45%)8.94USD455K成交股數2.0B市值12.8本益比(近四季)3.9股價營收比+2.0%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 124M+8% | 114M-3% | 134M+12% | 122M+14% | 115M+40% | 118M+75% | 120M+99% | 107M+88% | 81.9M | 67.3M | 60.1M | 56.9M |
| 營業成本 | 38.1M | 33.7M | 58.6M | 54.8M | 53.7M | 54.2M | 60.2M | 49.7M | 42.8M | 42.6M | 43.4M | 40.4M |
| 毛利 | 86.3M+41% | 80.8M+28% | 75.6M+27% | 67.2M+17% | 61.1M+56% | 63.3M+157% | 59.7M+257% | 57.5M+248% | 39.1M | 24.7M | 16.7M | 16.5M |
| 毛利率 | 69.4% | 70.5% | 56.3% | 55.1% | 53.2% | 53.9% | 49.8% | 53.6% | 47.8% | 36.6% | 27.8% | 29.0% |
| 研發費用 | 6.0M | 2.6M | 1.5M | 1.0M | 826K | 391K | 412K | 560K | 450K | 596K | 1.4M | 855K |
| 銷售管理費用 | 26.7M | 26.7M | 21.8M | 22.2M | 24.1M | 23.3M | 18.6M | 16.6M | 15.6M | 14.7M | 14.2M | 14.5M |
| 營業利益 | 52.4M+50% | 58.3M+52% | 51.0M+29% | 42.8M+9% | 34.9M+60% | 38.3M+341% | 39.6M-8480% | 39.2M-4922% | 21.8M | 8.7M | −473K | −813K |
| 營業利益率 | 42.2% | 50.9% | 38.0% | 35.1% | 30.4% | 32.6% | 33.1% | 36.6% | 26.7% | 12.9% | -0.8% | -1.4% |
| 稅後淨利 | 37.8M+41% | 45.3M-60% | 36.4M+1% | 34.2M+7% | 26.9M+51% | 112M+4263% | 35.9M-664% | 32.1M-572% | 17.8M | 2.6M | −6.4M | −6.8M |
| 淨利率 | 30.4% | 39.6% | 27.1% | 28.1% | 23.4% | 95.2% | 30.0% | 29.9% | 21.7% | 3.8% | -10.6% | -11.9% |
| 稀釋 EPS | 0.16+45% | 0.19-58% | 0.150% | 0.14+8% | 0.11+38% | 0.45+4400% | 0.15-600% | 0.13-533% | 0.08 | 0.01 | -0.03 | -0.03 |
| 稀釋股數 | 230M | 240M | 245M | 249M | 245M | 243M | 245M | 242M | 236M | 234M | 223M | 222M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 136M | 138M | 61.4M | 90.3M | 71.6M | 103M | 86.7M | 88.2M | 45.3M | 74.2M | 62.5M | 69.2M |
| 應收帳款 | 138M | 136M | 138M | 110M | 99.4M | 50.0M | 50.1M | 30.1M | 49.6M | 31.3M | 36.7M | 26.5M |
| 存貨 | 239M | 222M | 197M | 191M | 172M | 170M | 172M | 180M | 178M | 163M | 162M | 164M |
| 總資產 | 684M | 665M | 569M | 558M | 511M | 489M | 391M | 376M | 351M | 349M | 343M | 341M |
| 有息負債 | 193M | 194M | 70.1M | – | – | 72.3M | – | – | – | – | – | – |
| 總負債 | 276M | 275M | 138M | 160M | 137M | 140M | 159M | 188M | 197M | 198M | 196M | 195M |
| 股東權益 | 408M | 390M | 431M | 398M | 373M | 349M | 232M | 188M | 154M | 151M | 147M | 146M |
| 負債比 | 40.3% | 41.3% | 24.2% | 28.7% | 26.9% | 28.6% | 40.6% | 50.0% | 56.2% | 56.6% | 57.2% | 57.3% |
| 淨現金(現金 − 有息負債) | −56.8M | −55.4M | −8.7M | – | – | 30.8M | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 58.2M | – | – | −19.7M+787% | – | – | – | −2.2M | – | – | −14.7M |
| 資本支出 | – | 2.5M | – | – | 4.7M | – | – | – | 2.3M | – | – | 1.9M |
| 自由現金流 | – | 55.7M | – | – | −24.4M+434% | – | – | – | −4.6M | – | – | −16.7M |
| 折舊攤銷 | 1.7M | 1.8M | 2.0M | 2.0M | 1.9M | 2.0M | 1.9M | 1.9M | 1.9M | 1.9M | 1.9M | 1.9M |
| 買回庫藏股 | – | 130M | – | – | 0 | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 48.7% | – | – | -21.2% | – | – | – | -5.6% | – | – | -29.3% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 510M
| ADMA Bio Manufacturing | 493M | 96.7% | +18.5% |
|---|---|---|---|
| Plasma Collection Centers | 17.0M | 3.3% | +62.1% |
地區2025 年度 · 510M
| 美國 | 504M | 98.8% | +22.9% |
|---|---|---|---|
| 美國以外 | 6.1M | 1.2% | -62.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 510M | +19.6% | 147M | 28.8% | 0.60 | 27.8M |
| FY2024 | 426M | +65.2% | 198M | 46.4% | 0.81 | 110M |
| FY2023 | 258M | +67.6% | −28.2M | -10.9% | -0.13 | 4.0M |
| FY2022 | 154M | +90.4% | −65.9M | -42.8% | -0.33 | −73.4M |
| FY2021 | 80.9M | +91.7% | −71.7M | -88.5% | -0.51 | −126M |
| FY2020 | 42.2M | – | −75.7M | -179.4% | -0.88 | −115M |
| FY2020 | – | – | 321M | –% | – | – |
| FY2020 | – | – | 304M | –% | – | – |